Prof. Dr. İBRAHİM HALİL GÜLLÜ

Yayın Ağı

Makaleler 61

1. Analysis of patients with parotid recurrence after parotid-sparing IMRT for nasopharyngeal carcinoma: case series and review of the literature

YÜCE SARI S., Yilmaz M. T., YAZICI G., Mohammadipour S., ÖZYİĞİT G., Gullu İ. H., et al.

STRAHLENTHERAPIE UND ONKOLOGIE , sa.12, ss.1057-1065, 2024 (SCI-Expanded, Scopus)

2. Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)

AKYILDIZ A., GÜVEN D. C., KÖKSAL B., KARAOĞLAN B. B., Kivrak D., Ismayilov R., et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , cilt.281, sa.9, ss.4991-4999, 2024 (SCI-Expanded, Scopus)

3. The Relationship Between Microplastics and Nanoplastics with Cancer: An Emerging Health Concern

Yazarkan Y., Sonmez G., Tenekeci A. K., AKSOY E. A., GÜLLÜ İ. H.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.34, sa.2, ss.102-112, 2024 (SCI-Expanded, Scopus, TRDizin)

4. The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma

GÜVEN D. C., ERUL E., YILMAZ F., YAŞAR S., YILDIRIM H. Ç., ERCAN F., et al.

European Archives of Oto-Rhino-Laryngology , cilt.280, sa.5, ss.2471-2478, 2023 (SCI-Expanded, Scopus)

5. Post-induction lymph node delineation in nasopharyngeal cancer: A single-center experience.

Sari S., YİĞİT E., YAZICI G., GÜLLÜ İ. H., AKSOY S., ÖZYİĞİT G., et al.

Head & neck , cilt.45, sa.3, ss.612-619, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinoma

ERUL E., Guven D. C., ÖZBAY Y., ALTUNBULAK A. Y., KAHVECİOĞLU A., ERCAN F., et al.

Biomarkers in medicine , cilt.17, sa.2, ss.87-99, 2023 (SCI-Expanded, Scopus)

7. Results of concurrent radiotherapy and immunotherapy in recurrent and metastatic head and neck cancer: A single-center experience.

Sari S., Yilmaz M. T., Aktas B. Y., Aksoy S., Gullu İ. H., Cengiz M., et al.

Oral oncology , cilt.124, ss.105658, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. A novel agnostic tumor: NTRKoma

Ayasun R., GÜVEN D. C., Gullu İ. H.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.27, sa.4, ss.802-803, 2021 (SCI-Expanded, Scopus)

9. Thyroid gland metastasis mimicking thyroid carcinoma in a lung cancer patient and dramatic response to crizotinib: A case report

Erul E., GÜVEN D. C., ŞAHİN T. K., Gullu İ. H.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , cilt.69, sa.1, ss.98-101, 2021 (ESCI, Scopus, TRDizin)

10. Cancer incidence in Behcet's disease

GÜVEN D. C., BÖLEK E. Ç., ALTINTOP S. E., ÇELİKTEN B., AKTAŞ B. Y., KİRAZ S., et al.

IRISH JOURNAL OF MEDICAL SCIENCE , cilt.189, sa.4, ss.1209-1214, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Outcome of Elderly Nasopharyngeal Carcinoma Patients: A Single Center Study

Basaran H., CENGİZ M., YAZICI G., Ozdemir Y., SÜTAY SÜSLÜ N., GÜLLÜ İ. H., et al.

EUROPEAN JOURNAL OF THERAPEUTICS , cilt.26, sa.2, ss.129-134, 2020 (ESCI, TRDizin)

12. Cancer incidence in Behcet's Disease.

Guven D. C., Bolek E. C., Altintop S. E., Celikten B., Aktas B. Y., Kiraz S., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.38, sa.15, 2020 (SCI-Expanded, Scopus)

13. Neoadjuvant Chemotherapy Improves Survival in Patients with Locally Advanced Nasopharyngeal Carcinoma

Basaran H., CENGİZ M., YAZICI G., Susulu N., AKSOY S., HOŞAL A. Ş., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.29, sa.3, ss.176-185, 2019 (SCI-Expanded, Scopus, TRDizin)

14. Human papillomavirus infection in patients with laryngeal carcinoma

Celebi O. O., Sener E., Hosal S., CENGİZ M., Gullu İ. H., Tezel G. G.

BMC CANCER , cilt.18, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. The Synergistic Effect of Immune Checkpoint Blockade and Radiotherapy in Recurrent/Metastatic Sinonasal Cancer

YAZICI G., GÜLLÜ İ. H., CENGİZ M., ELMALI DOĞAN A., YILMAZ M. T., AKSOY S., et al.

Cureus , cilt.10, ss.3519, 2018 (ESCI)

16. Detection of O6-methylguanine-DNA methyltransferase gene promoter region methylation pattern using pyrosequencing and the effect of methylation pattern on survival, recurrence, and chemotherapy sensitivity in patients with laryngeal cancer

Celebi O. O., Tezel G. G., Hosal A. S., CENGİZ M., GÜLLÜ İ. H., HAYRAN K. M.

PATHOLOGY RESEARCH AND PRACTICE , cilt.212, sa.5, ss.456-462, 2016 (SCI-Expanded, Scopus)

17. Successful treatment of benign metastasizing leiomyoma with oral alternated chemotherapeutic agents

Sarici F., Babacan T., Altundag K., Balakan O., Gullu I.

JOURNAL OF BUON , cilt.18, sa.3, ss.799, 2013 (SCI-Expanded, Scopus)

18. Does Age Affect the Size of Metastatic Lymph Nodes in Head and Neck Cancer?

SÜSLÜ N., Hosal A. S., Tezel Y. G. G., Sozeri B., Gullu İ. H., Dolgun A.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.1, ss.13-19, 2013 (SCI-Expanded, Scopus, TRDizin)

19. Long-term advanced cholangiocarcinoma survivor with single-agent capecitabine

Petekkaya I., Gezgen G., Roach E. C., Solak M., Altundag K., Gullu I.

JOURNAL OF BUON , cilt.17, sa.4, ss.796, 2012 (SCI-Expanded, Scopus)

20. Ifosfamide and Doxorubicin Combination Chemotherapy for Recurrent Nasopharyngeal Carcinoma Patients

ŞENER DEDE D., AKSOY S., CENGİZ M., Gullu İ. H., Altundag K.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.5, ss.2225-2228, 2012 (SCI-Expanded, Scopus)

21. Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer

BULUT N., AKSOY S., DİZDAR Ö., Dede D. S., Arslan C., DOĞAN E., et al.

MEDICAL ONCOLOGY , cilt.28, 2011 (SCI-Expanded, Scopus)

22. A RETROSPECTIVE COMPARISON OF ROBOTIC STEREOTACTIC BODY RADIOTHERAPY AND THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY FOR THE REIRRADIATION OF LOCALLY RECURRENT NASOPHARYNGEAL CARCINOMA

ÖZYİĞİT G., CENGİZ M., YAZICI G., YILDIZ F., Gurkaynak M., Zorlu F., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.81, sa.4, 2011 (SCI-Expanded, Scopus)

23. SALVAGE REIRRADIATON WITH STEREOTACTIC BODY RADIOTHERAPY FOR LOCALLY RECURRENT HEAD-AND-NECK TUMORS

CENGİZ M., ÖZYİĞİT G., YAZICI G., DOĞAN A., YILDIZ F., Zorlu F., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.81, sa.1, ss.104-109, 2011 (SCI-Expanded, Scopus)

24. Sleep disturbance in patients with operable breast cancer receiving adjuvant hormone therapy

Aksoy S., Dede D. S., Yaman S., Ozkan C., Gullu İ. H., Altundag K.

JOURNAL OF CLINICAL ONCOLOGY , cilt.29, sa.15, 2011 (SCI-Expanded, Scopus)

25. Clinicopathologic features of patients with breast cancer under teatment of bisphosphonate at the time of diagnosis: Retrospective analysis

Dede D. S., Arslan C., Aksoy S., Dizdar O., Dogan E., Alkan A., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.29, sa.15, 2011 (SCI-Expanded, Scopus)

26. Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer

Sari E., Guler G., HAYRAN K. M., Gullu İ. H., Altundag K., Ozisik Y.

MEDICAL ONCOLOGY , cilt.28, sa.1, ss.57-63, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Blood ABO groups and risk of breast cancer

ŞENER DEDE D., AKSOY S., DİZDAR Ö., Cerci P., Gullu İ. H., Ozisik Y., et al.

MEDICAL ONCOLOGY , cilt.27, sa.4, ss.1433, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. FDG-PET/CT in the evaluation of epithelioid hemangioendothelioma of the liver: the role of dual-time-point imaging. A case presentation and review of the literature

KİTAPÇI M. T., Akkas B. E., Gullu İ. H., SÖKMENSÜER C.

ANNALS OF NUCLEAR MEDICINE , cilt.24, sa.7, ss.549-553, 2010 (SCI-Expanded, Scopus)

29. Addition of nine weeks of trastuzumab to adjuvant chemotherapy in operable HER2-positive breast cancer patients: Retrospective analysis.

Ozen M., Aksoy S., Dizdar O., Dede D. S., Dogan E., Arslan C., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.28, sa.15, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. Increased mean corpuscular volume of erythrocytes with capecitabine treatment in metastatic breast cancer patients: A marker of clinical benefit?

Aksoy S., Arslan C., Kurt M., Dizdar O., Dede D. S., Dogan E., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.28, sa.15, 2010 (SCI-Expanded, Scopus)

31. Docetaxel/doxorubicin/cyclophosphamide (TAC) chemotherapy for operable HER2-negative, node-positive breast cancer patients: Results from a single institution.

Surmell Z. G., Aksoy S., Dizdar O., Dede D. S., Dogan E., Arslan C., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.28, sa.15, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. Clinical and pathological characteristics of breast cancer patients with history of tonsillectomy

Isik M., AKSOY S., Dede D. S., DİZDAR Ö., Kara A., Gullu İ. H., et al.

BREAST , cilt.19, sa.2, ss.152, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

33. Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastases

Dincer M., Altundag K., Harputluoglu H., AKSOY S., CENGİZ M., Gullu İ. H.

MEDICAL ONCOLOGY , cilt.25, sa.3, ss.356-359, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Clinicopathologic evaluation of non-Hodgkin lymphoma (NHL): A single centre experience

Kilickap S., Barista I., Turkmen E., Dizdar O., Aksoy S., Turker A., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.26, sa.15, 2008 (SCI-Expanded, Scopus)

35. Characteristics of breast cancer patients with central nervous system metastases: A single-center experience

Harputluoglu H., DİZDAR Ö., AKSOY S., KILIÇKAP S., Dede D. S., Ozisik Y., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.100, sa.5, ss.521-526, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. Aromatase inhibitor-associated arthralgias: Pathogenesis, frequency and management

Altundag K., ŞENER DEDE D., Harputluoglu H., Gullu İ. H.

JOINT BONE SPINE , cilt.74, sa.6, ss.662-663, 2007 (SCI-Expanded, Scopus)

37. Potential molecular targeted therapies in the management of the basal-like subtype of breast cancer

KURT M., Harputluoglu H., ŞENER DEDE D., GÜLLÜ İ. H., Altundag K.

BREAST , cilt.16, sa.2, ss.111-112, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

38. Potential chemotherapy options in the triple negative subtype of breast cancer

Altundag K., Harputluoglu H., Aksoy S., Gullu İ. H.

JOURNAL OF CLINICAL ONCOLOGY , cilt.25, sa.10, ss.1294-1295, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

39. Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer

Cengiz M., Zorlu F., Yalcin S., Gurkaynak M., Atahan I. L., Gullu İ. H.

MEDICAL ONCOLOGY , cilt.24, sa.2, ss.239-243, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy

Turen S., Ozyar E., Altundag K., Gullu İ. H., Atahan I. L.

CANCER INVESTIGATION , cilt.25, sa.5, ss.315-321, 2007 (SCI-Expanded, Scopus)

41. How would you manage a rare cause of haemoptysis?

Ulubay G., Gorek A., Akcay S., Gullu I.

BREATHE , cilt.3, sa.2, ss.203-205, 2006 (ESCI, Scopus)

42. Mucosa associated lymphoid tissue lymphoma of the sub mandibular gland presenting with relapse in the lacrimal gland

KURT M., Shorbagi A., ALTUNDAĞ M. K., AKYÖN YILMAZ Y., DİZDAR Ö., GÜLLÜ İ. H.

Leukemia , cilt.47, ss.1982-1984, 2006 (SCI-Expanded)

43. Complications due to late diagnosis of celiac disease with co-existing plasma cell dyscrasia in an elderly patient

Cankurtaran M., Ulger Z., Dogan S., Yavuz B., Halil M., Gullu I., et al.

AGING CLINICAL AND EXPERIMENTAL RESEARCH , cilt.18, sa.1, ss.75-77, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. Peripheral T-cell lymphoma and Job's syndrome

Onal I., Kurt M., Altundag K., Aksoy S., Dincer M., Gullu I.

MEDICAL ONCOLOGY , cilt.23, sa.1, ss.141-144, 2006 (SCI-Expanded, Scopus)

45. Metastatic biology

GÜLLÜ İ. H., Akalin I.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.4, sa.4, ss.16-19, 2005 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

46. Possible association between Budd-Chiari syndrome and gemtuzumab ozogamicin treatment in a patient with refractory acute myelogenous leukemia

Kurt M., Shorbagi A., Altundag K., Elkiran T., Gullu I., Kansu E.

AMERICAN JOURNAL OF HEMATOLOGY , cilt.80, sa.3, ss.213-215, 2005 (SCI-Expanded, Scopus)

47. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: Results of single-center study of 45 patients

Altundag O., Gullu I., Altundag K., Yalcin S., Ozyar E., Cengiz M., et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , cilt.27, sa.1, ss.15-21, 2005 (SCI-Expanded, Scopus)

48. Acute tumor lysis syndrome triggered by zoledronic acid in a patient with metastatic lung adenocarcinoma

Kurt M., Onal I., Elkiran T., Altun B., Altundag K., Gullu I.

MEDICAL ONCOLOGY , cilt.22, sa.2, ss.203-206, 2005 (SCI-Expanded, Scopus)

49. Hypocalcemic effect of zoledronic acid or other bisphosphonates may contribute to their antiangiogenic properties

Aksoy S., Abali H., Dincer M., Kilickap S., Gullu I., Tekuzman G.

MEDICAL HYPOTHESES , cilt.62, sa.6, ss.942-944, 2004 (SCI-Expanded, Scopus)

50. Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis

Altundag O., Altundag K., Silay Y., Gunduz M., Demircan K., Gullu I.

MEDICAL HYPOTHESES , cilt.63, sa.6, ss.1010-1013, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

51. Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with cisplatin-based chemotherapy

Altundag K., Aksoy S., Gullu I., Altundag O., Ozyar E., Yalcin S., et al.

MEDICAL ONCOLOGY , cilt.21, sa.3, ss.211-215, 2004 (SCI-Expanded, Scopus)

52. Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer

Yalcin S., Oksuzoglu B., Tekuzman G., Engin H., Celik I., Turker A., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , cilt.33, sa.11, ss.580-583, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

53. Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: Efficacy and prognostic factors

Karaoglu A., Yalcin S., Tekuzman G., Kars A., Celik I., Guler N., et al.

TUMORI , cilt.89, sa.2, ss.141-145, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

54. Effects of growth factors on doxorubicin-induced skin necrosis: Documentation of histomorphological alterations and early treatment by GM-CSF and G-CSF

Vargel I., Erdem A., Ertoy D., Pinar A., Erk Y., Altundag M., et al.

ANNALS OF PLASTIC SURGERY , cilt.49, sa.6, ss.646-653, 2002 (SCI-Expanded, Scopus)

55. Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: Results of a single-center study of 32 patients

Ozturk M., Barista I., Altundag M., Turker A., Yalcin S., Celik I., et al.

CHEMOTHERAPY , cilt.48, sa.5, ss.252-258, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

56. Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists

Abali H., Gullu İ. H., Engin H., Haznedaroglu I., Erman M., Tekuzman G.

MEDICAL HYPOTHESES , cilt.59, sa.3, ss.344-348, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

57. Myasthenia gravis and lymphoblastic lymphoma involving the thymus: A rare association

Uner A., Abali H., Engin H., Akyol A., Ruacan E., Tan E., et al.

LEUKEMIA & LYMPHOMA , cilt.42, sa.3, ss.527-531, 2001 (SCI-Expanded, Scopus)

58. Primary breast lymphomas - A retrospective analysis of twelve cases

Barista I., Baltali E., Tekuzman G., Kars A., Ruacan S., Ozisik Y., et al.

ACTA ONCOLOGICA , cilt.39, sa.2, ss.135-139, 2000 (SCI-Expanded, Scopus)

59. Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy

Barista I., Tekuzman G., Yalcin S., Gullu I., Guler N., Ozisik Y., et al.

JOURNAL OF SURGICAL ONCOLOGY , cilt.73, sa.1, ss.12-16, 2000 (SCI-Expanded, Scopus)

60. Maintenance therapy with alpha-interferon following first-line VAD in multiple myeloma

Kars A., Celik İ., Kansu E., Tekuzman G., Ozisik Y., Guler N., et al.

EUROPEAN JOURNAL OF HAEMATOLOGY , cilt.59, sa.2, ss.100-104, 1997 (SCI-Expanded, Scopus)

61. Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections

Akova M., Ozcebe O. İ., Gullu I., Unal S., GUR D., AKALIN S., et al.

JOURNAL OF CHEMOTHERAPY , cilt.8, sa.4, ss.284-289, 1996 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 17

1. Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).

Akyildiz A., Guven D. C., Koksal B., Karaoglan B. B., Salim D. K., Sutcuoglu O., et al.

Special Clinical Science Symposia, ELECTR NETWORK, 29 Mayıs 2024, (Özet Bildiri)

2. Adjuvan Yoğunluk Ayarlı Radyoterapi Uygulanan Baş-Boyun Kanserli Olgularda Tedavi Sonuçlarımız.

YÜCE SARI S., CENGİZ M., YAZICI G., ELMALI DOĞAN A., BEDÜK Ç. S., GÜLLÜ İ. H., et al.

13.Ulusal Radyasyon Onkolojisi Kongresi, Türkiye, 27 Nisan - 01 Mayıs 2018, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

3. Baş-Boyun Melanomlarında Radyoterapi Sonuçlarımız

YÜCE SARI S., YAZICI G., CENGİZ M., YILMAZ M. T., AKSOY S., GÜLLÜ İ. H., et al.

13. ULUSAL RADYASYON ONKOLOJİSİ KONGRESİ, Türkiye, 27 Nisan - 01 Mayıs 2018, (Tam Metin Bildiri)

4. Definitif Radyoterapi Uygulanan Lokal İleri Evre Larinks Kanserli Hastalarda Hematolojik Parametrelerin Sağkalım Üzerine Prognostik Etkisi

YÜCE SARI S., CENGİZ M., GÜLTEKİN M., SÜSLÜ N., YAZICI G., HAYRAN K. M., et al.

22. UKK, Türkiye, 19 - 23 Nisan 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Survival and Larynx Preservation Rates after Definitive Radiotherapy A Single Center Experience

CENGİZ M., YÜCE SARI S., GÜLTEKİN M., SÜSLÜ N., AKSOY S., KUŞCU O., et al.

ECHNO 2016, Budapest, Macaristan, 7 - 10 Eylül 2016, (Özet Bildiri)

6. The impact of the total size of lesions in multifocal multicentric breast cancer on survival

Karakaş Y., DİZDAR Ö., Akın S., ATEŞ Ö., ŞENDUR M. A. N., AKSOY S., et al.

2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

7. Modified docetaxel cisplatin and fluorouracil therapy as a first line treatment for patients with recurrent metastatic squamous cell carcinoma of the head and neck cancer a retrospective study

DEMİRCİ N., AKSOY S., ÖZDEMİR N., Babacan T., ERDEM G. U., BOZKAYA Y., et al.

2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

8. The impact of the total size of lesions in multifocal/multicentric breast cancer on survival.

Karakas Y., Dizdar O., Akin S., Ates O., Sendur M. A. N., Aksoy S., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34, (Özet Bildiri) Sürdürülebilir Kalkınma

9. Radiation Therapy Results of Patients With Adenoid Cystic Carcinoma

GÜLTEKİN M., CENGİZ M., Sari S. Y., HOŞAL Ş., YAZICI G., SÜSLÜ N., et al.

57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San-Antonio, Kuzey Mariana Adaları, 18 - 21 Ekim 2015, cilt.93, (Özet Bildiri)

10. Comparison of three different induction regimen in nasopharyngeal cancer: CF versus DC versus DCF.

Kertmen N., Aksoy S., Cengiz M., Yazici G., Keskin O., Babacan T., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri) Sürdürülebilir Kalkınma

11. Early stage "T2N0" breast cancer: Does it consist two different "T2" stages?

Arslan C., Sahin U., Kizilarslanoglu C., Solak M., Gullu I. H., Ozisik Y., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

12. Outcomes of patients with HER2-negative breast cancer with central nervous system metastasis treated with capecitabine.

Altundag K., Aksoy S., Sendur M. A. N., Guler E. N., Gullu I. H., Ozisik Y. Y.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

13. Comparison of ER, PR, HER2 in primary and paired relapsed/metastatic lesions of metastatic breast cancer patients

SARI E., Guler G., HAYRAN K. M., Altundag K., GÜLLÜ İ. H., Ozisik Y.

45th Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2009, cilt.27, (Özet Bildiri) Sürdürülebilir Kalkınma

14. Comparison of serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of metastases and serum levels at the time of first diagnosis

Dede D. S., Aksoy S., Bulut N., Dizdar O., Arik Z., Gullu I., et al.

45th Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2009, cilt.27, (Özet Bildiri) Sürdürülebilir Kalkınma

15. Characteristics of breast cancer patients with central nervous system metastases and factors associated with survival after development of central nervous system metastasis

Harputluoglu H., Dizdar O., Aksoy S., Kilickap S., Dede D. S., Ozisik Y., et al.

30th Annual San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 13 - 16 Aralık 2007, cilt.106, (Özet Bildiri) Sürdürülebilir Kalkınma

16. Serum LDH level is a prognostic factor in locoregionally advanced nasopharyngeal carcinoma (NPC) patients treated with chemoradiotherapy

Turen S., Ozyar E., Altundag K., Gullu I., Atahan I.

23rd Annual Meeting of the European-Society-for-Therapeutic-Radiology-and-Oncology (ESTRO 23), Amsterdam, Hollanda, 24 - 28 Ekim 2004, cilt.73, (Özet Bildiri)

17. Clinicopathological features and outcome of primary gastric lymphoma: A series of 73 cases

Oyan B., Tekuzman G., Barista I., Kars A., Turker A., Ozisik Y., et al.

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

672

H-İndeks (WoS)

Atıf (Scopus)

621

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler